Second edition of Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.

It’s our pleasure to share with you the second Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.

ALLG News is for people, like you, who are interested in medical research and ALLG’s mission to create better treatments and better lives for patients with blood cancers.

Our international clinical trial collaborations bring new treatments to Australians and New Zealanders; including patients just like New Zealander Hemi Frires, a Royal New Zealand Air Force pilot who joined an ALLG clinical trial for the treatment of his Hodgkin Lymphoma. You can read Hemi’s story, and more, in this newsletter.

As the only non-profit collaborative clinical trials groups in Australia and New Zealand for blood cancers, ALLG has the capability to run independent doctor-led clinical trials in Australasia and, crucially, to participate in international trials; allowing us access to new drugs with the potential to make a significant impact on patient outcome.

We hope you enjoy reading about ALLG’s world-leading blood cancer research and the impact your support has for patients with blood cancers. We look forward to sharing more news with you in the New Year 2023, which will be the ALLG’s 50th Anniversary year.

You can read ALLG News Edition 2 here.

You can subscribe to future editions of ALLG News here.